Michael Diamond to Vero Cells
This is a "connection" page, showing publications Michael Diamond has written about Vero Cells.
Connection Strength
0.810
-
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature. 2021 08; 596(7870):103-108.
Score: 0.069
-
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 04; 27(4):717-726.
Score: 0.067
-
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell. 2021 04 01; 184(7):1804-1820.e16.
Score: 0.067
-
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol. 2020 11; 21(11):1327-1335.
Score: 0.065
-
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2. Cell. 2020 10 01; 183(1):169-184.e13.
Score: 0.065
-
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice. Cell Host Microbe. 2020 09 09; 28(3):465-474.e4.
Score: 0.064
-
Growth, detection, quantification, and inactivation of SARS-CoV-2. Virology. 2020 09; 548:39-48.
Score: 0.064
-
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies. Cell. 2020 08 06; 182(3):744-753.e4.
Score: 0.064
-
Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infections. Cell Rep. 2018 03 27; 22(13):3440-3453.e6.
Score: 0.055
-
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations. J Mol Biol. 2021 09 17; 433(19):167177.
Score: 0.017
-
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. 2021 08; 596(7870):109-113.
Score: 0.017
-
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell. Cell Rep. 2021 07 13; 36(2):109364.
Score: 0.017
-
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell. 2021 04 29; 184(9):2316-2331.e15.
Score: 0.017
-
A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence. Cell. 2021 04 15; 184(8):2229-2238.e13.
Score: 0.017
-
The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021 04 15; 184(8):2183-2200.e22.
Score: 0.017
-
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe. 2021 03 10; 29(3):477-488.e4.
Score: 0.017
-
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021 03; 591(7849):293-299.
Score: 0.017
-
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors. Science. 2020 10 23; 370(6515):426-431.
Score: 0.016
-
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2. Cell Host Microbe. 2020 09 09; 28(3):475-485.e5.
Score: 0.016
-
A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. J Immunol. 2020 08 15; 205(4):915-922.
Score: 0.016
-
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020 07; 583(7815):290-295.
Score: 0.016
-
Zika virus has oncolytic activity against glioblastoma stem cells. J Exp Med. 2017 Oct 02; 214(10):2843-2857.
Score: 0.013
-
The transmembrane domain of the severe acute respiratory syndrome coronavirus ORF7b protein is necessary and sufficient for its retention in the Golgi complex. J Virol. 2008 Oct; 82(19):9477-91.
Score: 0.007
-
Structure, expression, and intracellular localization of the SARS-CoV accessory proteins 7a and 7b. Adv Exp Med Biol. 2006; 581:115-20.
Score: 0.006
-
Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein. Structure. 2005 Jan; 13(1):75-85.
Score: 0.005